EchoNous Closes $60M for AI-Assisted Handheld Ultrasound Device

What You Should Know:

EchoNous, a Redmond, WA-based portable AI-guided ultrasound tools and platform, announced it has raised $60 million in funding from Kennedy Lewis Investment Management (“Kennedy Lewis”).

– The investment from Kennedy Lewis combines senior secured debt and equity and builds on the support of KKR, which has been EchoNous’ principal investor since 2015. Kennedy Lewis’ funding will help further the development of and grow adoption for the Kosmos platform, which is already used in hospitals and medical clinics around the world.

– Kosmos is transforming bedside diagnosis of heart and lung conditions. It’s the first handheld point-of-care ultrasound device to offer diagnostic-quality scans that rival those from larger, more expensive cart-based machines. In addition, it is the first handheld to offer CW and PW Doppler and AI guidance for scans of heart chambers.